Green Cross Holdings Corporation

KOSE:A005250 Rapporto sulle azioni

Cap. di mercato: ₩749.3b

Green Cross Holdings Performance dei guadagni passati

Il passato criteri di controllo 0/6

Gli utili di Green Cross Holdings sono diminuiti a un tasso medio annuo di -50.5%, mentre il settore Biotechs ha visto gli utili crescere a un tasso medio annuo di 7.2%. I ricavi sono cresciuti crescere a un tasso medio annuo di 7.9%.

Informazioni chiave

-50.5%

Tasso di crescita degli utili

-50.5%

Tasso di crescita dell'EPS

Biotechs Crescita del settore11.7%
Tasso di crescita dei ricavi7.9%
Rendimento del capitale proprio-6.1%
Margine netto-3.6%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Jan 12
We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Recent updates

Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?

Aug 09
Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?

Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend

Apr 28
Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend

Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?

Mar 21
Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?

Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt

Mar 01
Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt

If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today

Feb 12
If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today

Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like

Jan 28
Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like

We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Jan 12
We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings

Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend

Dec 28
Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend

Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 13
Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky

Nov 28
Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky

Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking

Nov 28
Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking

Ripartizione dei ricavi e delle spese

Come Green Cross Holdings guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

KOSE:A005250 Ricavi, spese e utili (KRW Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 242,113,064-75,257428,947162,912
31 Mar 242,089,633-68,156426,954168,083
31 Dec 232,057,936-53,448419,632179,470
30 Sep 232,022,765-4,467426,537196,019
30 Jun 232,034,7386,689418,055204,932
31 Mar 232,015,4899,763416,239208,850
31 Dec 222,079,56033,457408,479193,945
30 Sep 222,080,21014,585401,716184,627
30 Jun 222,057,37232,002395,429177,894
31 Mar 221,997,19739,712388,835154,316
31 Dec 211,840,55954,901376,468147,282
30 Sep 211,839,7429,620361,495147,785
30 Jun 211,775,10029,238347,233135,340
31 Mar 211,722,66565,565319,163141,602
31 Dec 201,719,32660,806301,464143,311
30 Sep 201,612,25396,771270,036128,912
30 Jun 201,540,22072,006251,017127,916
31 Mar 201,488,62448,269225,374127,162
31 Dec 191,493,58942,741221,067126,347
30 Sep 191,492,85229,228222,126122,954
30 Jun 191,496,67718,310221,204124,867
31 Mar 191,551,002-222227,157124,320
31 Dec 181,548,71518,465221,863122,405
30 Sep 181,519,20826,751204,758119,275
30 Jun 181,522,76638,297198,275115,068
31 Mar 181,494,55059,556191,544108,345
31 Dec 171,465,48943,364185,640103,749
30 Sep 171,479,23562,679178,320108,474
30 Jun 171,433,08455,552173,950109,047
31 Mar 171,397,33150,325175,393110,624
31 Dec 161,354,46647,177172,994109,210
30 Sep 161,272,15725,266174,099109,676
30 Jun 161,224,59547,651167,153101,413
31 Mar 161,169,78157,849159,51297,034
31 Dec 151,132,87765,421154,01595,507
30 Sep 151,106,56366,458148,70083,567
30 Jun 151,093,49364,003149,36280,311
31 Mar 151,057,32252,063144,30375,281
31 Dec 141,044,76856,761141,52975,014
30 Sep 141,030,19454,428134,89974,901
30 Jun 141,006,09543,922128,92676,938
31 Mar 14973,48643,473125,95675,662
31 Dec 13938,29843,550123,46972,961

Guadagni di qualità: A005250 al momento non è redditizia.

Margine di profitto in crescita: A005250 al momento non è redditizia.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: A005250 non è redditizia e le perdite sono aumentate negli ultimi 5 anni a un tasso pari a 50.5% all'anno.

Accelerare la crescita: Impossibile confrontare la crescita degli utili di A005250 nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia

Guadagni vs Settore: A005250 non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Biotechs ( 6.1% ).


Rendimento del capitale proprio

ROE elevato: A005250 ha un Return on Equity negativo ( -6.09% ), in quanto al momento non è redditizio.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate